Florida Cancer Specialists & Research Institute, LLC (FCS) is pleased to welcome hematologist and medical oncologist Sireesha Datla, MD to the statewide practice.
Florida Cancer Specialists & Research Institute, LLC (FCS) is pleased to announce that Board-certified hematologist and medical oncologist Jayan Nair, MD has joined the the Sarasota Downtown clinical team.
Florida Cancer Specialists & Research Institute, LLC (FCS) is pleased to announce the promotion of a member of its executive leadership team, Paul Chadwick, to Chief Value and Procurement Officer. Paul will continue reporting to Chief Executive Officer Nathan H. Walcker. The statewide practice also welcomed Frank Scimeca, PharmD, MBA, BCOP as vice president, pharmacy services, reporting to Paul Chadwick, effective July 17, 2023.
FCS physicians and senior leaders are co-authors of a study that confirms the effectiveness of trilaciclib for the treatment of adult patients with Extensive-Stage Small Cell Lung Cancer. Trilaciclib is the first FDA-approved therapy in its class to help protect bone marrow cells from damage caused by chemotherapy.
Lucio Gordan, MD, President & Managing Physician of Florida Cancer Specialists & Research Institute, LLC (FCS), talked with Kevin Keegan, General Manager of Oncology Business with Illumina, about how FCS is bringing precision oncology through analysis of real-world data, innovative technology and research to cancer patients being treated in community settings.
FCS Top News Updates
FCS Contributing To Breakthroughs In Treatment of Blood Cancers & Disorders
Tien Do, MD joins FCS Tallahassee Cancer CenterHematologist and medical oncologist Tien Do, MD joins Florida Cancer Specialists & Research Institute Tallahassee Cancer Center
Sireesha Datla, MD Joins FCSFlorida Cancer Specialists & Research Institute, LLC (FCS) is pleased to welcome hematologist and medical oncologist Sireesha Datla, MD to the statewide practice.
Jayan Nair, MD Joins Clinical Team at FCS Sarasota Downtown LocationFlorida Cancer Specialists & Research Institute, LLC (FCS) is pleased to announce that Board-certified hematologist and medical oncologist Jayan Nair, MD has joined the the Sarasota Downtown clinical team.
FCS Announces Senior Leadership Team AppointmentFlorida Cancer Specialists & Research Institute, LLC (FCS) is pleased to announce the promotion of a member of its executive leadership team, Paul Chadwick, to Chief Value and Procurement Officer. Paul will continue reporting to Chief Executive Officer Nathan H. Walcker. The statewide practice also welcomed Frank Scimeca, PharmD, MBA, BCOP as vice president, pharmacy services, reporting to Paul Chadwick, effective July 17, 2023.
FCS Co-authored Study Confirms Effectiveness of Trilaciclib for Treatment of Patients with Extensive-Stage Small Cell Lung CancerFCS physicians and senior leaders are co-authors of a study that confirms the effectiveness of trilaciclib for the treatment of adult patients with Extensive-Stage Small Cell Lung Cancer. Trilaciclib is the first FDA-approved therapy in its class to help protect bone marrow cells from damage caused by chemotherapy.
After ChemotherapyAfter chemotherapy there are a few important things to remember and rules to follow, this list will walk you through the dos and don’ts.
Chemotherapy Instructions For PatientsInstructions for managing chemotherapy side effects during treatment. Things to watch for, what to avoid and when to call the doctor.
Precision Medicine at Scale is HereLucio Gordan, MD, President & Managing Physician of Florida Cancer Specialists & Research Institute, LLC (FCS), talked with Kevin Keegan, General Manager of Oncology Business with Illumina, about how FCS is bringing precision oncology through analysis of real-world data, innovative technology and research to cancer patients being treated in community settings.